Clinical trial
Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack
NCT00093197 · KAI Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00093197 |
|---|---|
| Title | Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack |
| Official title | Intracoronary KAI-9803 for Injection as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction |
| Lead sponsor | KAI Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | KAI-9803 for Injection, Placebo |
| Enrollment | 154 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Oct 7, 2004 |
| Last update posted | Sep 2, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: